Followers | 0 |
Posts | 12 |
Boards Moderated | 0 |
Alias Born | 10/13/2005 |
Friday, October 14, 2005 1:57:08 PM
MAIN FACTS:
Employees -- 3,000 in 14 countries
Futures accounts worldwide - 250,000
Assets - over $20 billion
Client equity - over $4 billion
Shares outstanding - 127.5 million
OPERATIONS:
Refco Inc: Holding company for Refco's operations.
Refco Capital Markets: Brokerage services for execution, clearing, securities financing and lending, custody and trade processing, primarily in U.S. Treasuries and foreign exchange.
Refco Global Futures: Allows customers to trade in interest rate and equity index swaps, energy agriculture, foreign exchange and metals contracts across all derivatives markets.
Derivatives
In 2004 was the largest provider of customer transaction volume to the Chicago Mercantile Exchange. In its fiscal 2005 year processed more derivative contracts than the Chicago Board of Trade, the Chicago Board Options Exchange or the New York Mercantile Exchange.
Treasuries
Cleared over $13.7 trillion in U.S. Treasury repurchase transactions, the eighth largest in terms of cash transaction volume.
Foreign Exchange
Global foreign exchange transactions tripled in last three fiscal years to $1.22 billion in fiscal 2005.
Revenues
$1.3 billion in fiscal 2005, a compound annual growth rate of 23.6 percent since 2000.
Operating Profit
$150.6 million in fiscal 2005, a compound annual growth rate of 19.8 percent since 2000.
Stockholders
THL (affiliate of Thomas H. Lee Partners): 42.7 percent
Phillip Bennett (former chief executive), directors and management: 36.5 percent.
Public shareholders: 20.8 percent.
Phillip Bennett's salary (fiscal 2005): $4 million.
(Source: Refco's IPO filing)
Recent QQQ News
- Invesco QQQ Celebrates 25 years of Access to Innovation • PR Newswire (US) • 03/11/2024 01:00:00 PM
- Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 02/29/2024 09:58:50 PM
- Form 497J - Certification of no change in definitive materials • Edgar (US Regulatory) • 01/30/2024 07:52:57 PM
- Form 485BPOS - Post-effective amendment [Rule 485(b)] • Edgar (US Regulatory) • 01/26/2024 08:42:59 PM
- Form N-30B-2 - Periodic and interim reports mailed to shareholders • Edgar (US Regulatory) • 12/28/2023 04:16:55 PM
- Form 24F-2NT - Rule 24F-2 notice • Edgar (US Regulatory) • 12/22/2023 04:52:05 PM
- Annual Changes to the Nasdaq-100 Index® • GlobeNewswire Inc. • 12/09/2023 01:00:00 AM
- Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 08/29/2023 03:44:15 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM